Cancer Research UK and Guardant Health have initiated a collaborative effort focused on advancing cancer research and clinical development activities. This partnership, announced on December 4, 2023, aims to leverage the Cancer Research UK-funded research network to further develop and validate Guardant Health’s technologies, particularly its Infinity platform. This collaboration is expected to support the UK-based cancer charity’s clinical development activities and is a part of a broader mission to accelerate the discovery and development of cancer drugs and diagnostics for patients.
Guardant Health plans to expand its partnership with Cancer Research UK, one of the world’s leading cancer charities. This collaboration combines Guardant Health’s cutting-edge biotechnology with Cancer Research UK’s extensive reach, encompassing more than 200 clinical trials and studies involving over a million people in the UK.